Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC In Germany

Reuters
2025.12.04 18:30
portai
I'm PortAI, I can summarize articles.

Dec 4 (Reuters) - Halozyme Therapeutics Inc:HALOZYME WINS PRELIMINARY INJUNCTION AGAINST MERCK’S KEYTRUDA SC IN GERMANYHALOZYME THERAPEUTICS: AS CONSEQUENCE OF INJUNCTION MERCK’S LAUNCH ACTIVITIES FOR KEYTRUDA SC IN GERMANY WITHIN SCOPE OF ORDER MUST BE HALTEDHALOZYME THERAPEUTICS: OUTCOME OF THE INFRINGEMENT LAWSUIT AGAINST MERCK WILL NOT IMPACT ENHANZEHALOZYME THERAPEUTICS INC - IV VERSION OF KEYTRUDA REMAINS AVAILABLE TO PATIENTS Source text: Further company coverage:

Dec 4 (Reuters) - Halozyme Therapeutics Inc (HALO.O) :

  • HALOZYME WINS PRELIMINARY INJUNCTION AGAINST MERCK’S KEYTRUDA SC IN GERMANY
  • HALOZYME THERAPEUTICS: AS CONSEQUENCE OF INJUNCTION MERCK’S LAUNCH ACTIVITIES FOR KEYTRUDA SC IN GERMANY WITHIN SCOPE OF ORDER MUST BE HALTED
  • HALOZYME THERAPEUTICS: OUTCOME OF THE INFRINGEMENT LAWSUIT AGAINST MERCK WILL NOT IMPACT ENHANZE
  • HALOZYME THERAPEUTICS INC - IV VERSION OF KEYTRUDA REMAINS AVAILABLE TO PATIENTS Source text: Further company coverage: (HALO.O)
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer